An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Acadia Pharmaceuticals seeks a seasoned medical affairs professional to lead content development and scientific review for neurological and rare disease programs. You will oversee the creation and validation of materials used in corporate, investor, and medical communications, ensuring regulatory and scientific accuracy.
The role requires MD/PhD/PharmD with extensive experience in Medical Affairs, strong analytical and communication skills, and capability to navigate regulatory review processes.
Lead medical content development and scientific review within Medical Affairs for Acadia Pharmaceuticals, supporting communication on neurological and rare disease treatments.
oversee creation and review of scientific materials (e.g., slide decks, congress content, digital resources); collaborate with stakeholders for content management plans; ensure scientific accuracy across corporate, investor, commercial, and medical communications; interpret complex data and literature; serve as a subject matter expert on product knowledge, regulatory review processes, and therapeutic areas including Parkinson’s disease psychosis, Rett syndrome, Alzheimer’s, and Lewy body dementia.
PharmD, PhD, or MD; 7+ years in Medical Affairs, with 5+ years in Scientific Communications or Medical Information; experience supporting scientific exchange activities; strong analytical, communication, and regulatory knowledge.
experience in neuroscience or neurodegenerative diseases, familiarity with MLR/MRC processes, and proficiency with scientific literature evaluation.
neurological and rare diseases, mid- to late-stage clinical programs, scientific content creation, regulatory review, cross-functional collaboration, and remote work with travel as needed.